Theratechnologies Inc (TH.TO) Quote| Reuters.com
Edition:
United States

Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

2.70CAD
4:00pm EDT
Change (% chg)

$-0.05 (-1.82%)
Prev Close
$2.75
Open
$2.78
Day's High
$2.78
Day's Low
$2.67
Volume
56,959
Avg. Vol
306,549
52-wk High
$3.74
52-wk Low
$1.26

TH.TO

Chart for TH.TO

About

Theratechnologies Inc. is a Canada-based specialty pharmaceutical company. The Company addresses medical needs in metabolic disorders to promote healthy ageing among human immunodeficiency virus (HIV) patients. The Company's product, EGRIFTA (tesamorelin for injection), is used for the reduction of excess abdominal fat in... (more)

Overall

Beta: 1.98
Market Cap(Mil.): $181.32
Shares Outstanding(Mil.): 65.93
Dividend: --
Yield (%): --

Financials

  TH.TO Industry Sector
P/E (TTM): 74.12 33.67 34.69
EPS (TTM): 0.04 -- --
ROI: 8.19 14.91 14.13
ROE: 16.79 15.99 15.35

BRIEF-Theratechnologies and partner evaluating steps to seek and obtain approval of 1 mg/vial presentation

* Decided to withdraw marketing authorization application for registration of 2 mg/vial presentation of tesamorelin in Brazil

May 16 2016

BRIEF-Theratechnologies Q1 earnings per share C$0.00

* Theratechnologies announces financial results for first quarter of 2016

Mar 31 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.